MannKind Corp
MNKD
#6062
Rank
$1.03 B
Marketcap
$3.35
Share price
-0.30%
Change (1 day)
-30.35%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): $1.4 Million USD

According to MannKind Corp's latest financial reports the company's current earnings are $0.34 Billion USD. a decrease over its 2024 earnings that were of $30.51 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 $1.4 M-95.39%
2024 $30.51 M-394.09%
2023 -$10.38 Million-88.13%
2022 -$87.4 Million8%
2021 -$80.93 Million40.84%
2020 -$57.46 Million10.7%
2019 -$51.91 Million-40.16%
2018 -$86.74 Million-26.04%
2017 -$0.12 Billion-193.33%
2016 $0.12 B-134.11%
2015 -$0.37 Billion85.72%
2014 -$0.2 Billion3.6%
2013 -$0.2 Billion12.79%
2012 -$0.17 Billion5.58%
2011 -$0.17 Billion-5.72%
2010 -$0.18 Billion-22.51%
2009 -$0.23 Billion-27.37%
2008 -$0.31 Billion3.36%
2007 -$0.3 Billion27.18%
2006 -$0.24 Billion101.63%
2005 -$0.12 Billion50.46%
2004 -$76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 752,636.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$25.01 B 1,777,575.91%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
$31.12 B 2,212,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B 934,654.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
$0.46 B 33,082.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-$0.16 Billion-11,150.96%๐Ÿ‡บ๐Ÿ‡ธ USA